pathogen
invas
host
elicit
variou
defenc
mechan
protect
host
type
interferon
central
role
regul
respons
induct
hundr
interferonstimul
gene
isg
review
among
isg
ubiquitinlik
protein
one
induc
recent
work
shown
directli
inhibit
viral
replic
modul
host
immun
member
ubiquitin
famili
includ
ubiquitin
ubiquitinlik
modifi
ubl
ubiquitin
ubl
involv
regul
varieti
cellular
activ
includ
protein
stabil
intracellular
traffick
cell
cycl
control
immun
modul
wherea
ubl
constitut
present
host
cell
other
induc
differ
stimuli
member
enzymat
cascad
mediat
conjug
isgyl
strongli
induc
type
coval
conjug
onto
target
protein
via
enzymat
cascad
yet
fate
modifi
protein
still
larg
unknown
addit
exist
unconjug
protein
report
function
cytokin
also
interact
variou
intracellular
protein
partner
progress
made
defin
mechan
isgyl
viral
host
protein
inhibit
viral
replic
viral
evas
strategi
evolv
circumv
yet
recent
advanc
field
highlight
complex
pathway
increas
evid
unconjug
regul
viral
replic
host
respons
noncoval
protein
interact
action
cytokin
human
genet
evid
patient
reveal
import
regul
type
interferon
patient
display
type
interferon
autoinflamm
appar
increas
suscept
viral
infect
compar
mice
indic
function
divers
review
discuss
basic
biolog
characterist
isgyl
pathway
regul
viral
replic
immunomodulatori
properti
viral
evas
strategi
evolv
circumv
first
identifi
studi
type
interferontr
compos
two
ubiquitinlik
domain
amino
acid
sequenc
homolog
ubiquitin
link
short
hing
addit
strongli
induc
type
interferon
also
induc
viral
bacteri
lipopolysaccharid
lp
retino
certain
genotox
indic
express
repres
host
respons
pathogen
stimuli
exist
kda
precursor
protein
rapidli
process
matur
kda
form
via
proteas
cleavag
expos
carboxytermin
lrlrgg
coval
conjug
target
protein
motif
threestep
process
known
isgyl
review
fig
date
hundr
put
target
isgyl
identifi
use
mass
spectrometri
howev
subset
tabl
function
consequ
isgyl
still
poorli
understood
unlik
ubiquityl
isgyl
appear
directli
target
protein
proteasomemedi
studi
specif
isgyl
protein
found
compet
ubiquitin
ubiquitin
bind
site
protein
therebi
indirectli
regul
protein
addit
mix
chain
observ
may
neg
regul
turnov
ubiquityl
howev
everi
isgyl
protein
studi
small
fraction
total
pool
protein
modifi
make
challeng
understand
isgyl
impact
overal
function
protein
one
possibl
modif
protein
alter
cellular
local
function
seen
isgyl
filamin
addit
protein
multimer
polymer
modif
small
fraction
protein
could
disrupt
assembl
protein
complex
observ
influenza
b
viru
ibv
human
papilloma
viru
hpv
see
discuss
isgyl
revers
deconjug
enzym
ubl
carboxytermin
hydrolas
specif
achiev
hydrophob
interact
hydrophob
patch
hydrophob
region
uniqu
note
independ
deconjug
activ
also
bind
second
chain
interferon
receptor
complex
compet
janu
kinas
bind
therefor
function
neg
regul
interferon
thu
studi
involv
need
interpret
caution
differenti
effect
conjug
dysregul
interferon
also
exist
unconjug
protein
vivo
detect
serum
patient
treat
interferon
viral
infect
extracellular
propos
function
cytokin
sever
immunomodulatori
activ
includ
induct
natur
killer
nk
cell
stimul
induct
dendrit
cell
function
chemotact
factor
mechan
releas
unclear
contain
leader
signal
howev
recent
studi
shown
could
releas
via
nonconvent
secret
includ
releas
neutrophil
granul
secretori
lysosom
via
recent
lymphocyt
functionassoci
antigen
identifi
cell
surfac
receptor
extracellular
bind
stimul
releas
prime
impact
extracellular
exert
viral
infect
remain
determin
recent
shown
similar
ubiquitin
free
intracellular
noncoval
bind
intracellular
protein
modul
fig
free
intracellular
shown
bind
block
enzymat
activ
also
shown
regul
type
interferon
signal
stabil
interact
leucinerich
repeatcontain
protein
mediat
autophag
degrad
retino
acidinduc
gene
protein
rigi
also
known
follow
section
discuss
recent
insight
isgyl
role
free
intracellular
extracellular
viral
infect
isgyl
local
ligas
polyribosom
target
nascent
protein
make
viral
protein
domin
protein
within
infect
cell
like
although
extens
character
protein
isgyl
differ
viral
infect
report
sever
viral
protein
identifi
substrat
conjug
fig
studi
exampl
isgyl
viral
protein
disrupt
interact
host
pathway
requir
replic
disrupt
oligomer
viral
protein
andor
geometri
viru
disrupt
viral
protein
function
result
reduc
viral
replic
alter
host
immun
respons
first
viral
protein
found
modifi
nonstructur
protein
iav
crucial
viral
replic
inhibit
induct
type
block
activ
protein
kinas
r
pkr
select
enhanc
viral
mrna
interfer
cellular
mrna
modif
lysin
posit
inhibit
nuclear
transloc
disrupt
interact
leav
viru
suscept
inhibit
interferon
second
studi
isgyl
distinct
site
disrupt
interact
sever
bind
partner
includ
amino
terminu
pkr
rnabind
domain
small
nuclear
rna
snrna
doublestrand
rna
dsrna
limit
abil
disrupt
host
antivir
togeth
find
provid
initi
evid
modifi
viral
protein
directli
antagon
viru
replic
proteas
also
target
protein
mediat
cleavag
mammalian
eukaryot
translat
initi
factor
result
shutoff
host
cell
protein
synthesi
turn
promot
viral
replic
isgyl
hinder
cleavag
infect
diminish
host
cell
shutoff
reduc
studi
ibv
hpv
suggest
isgyl
viral
protein
block
oligomer
disrupt
function
geometri
viral
complex
oligomer
ibv
nucleoprotein
np
form
viral
ribonucleoprotein
vrnp
requir
viral
rna
synthesi
isgyl
ibv
np
act
dominantneg
inhibitor
oligomer
unmodifi
np
restrict
viral
rna
synthesi
reduc
ibv
hpv
capsid
protein
also
isgyl
incorpor
viral
particl
number
infect
particl
incorpor
isgyl
protein
found
decreas
possibl
owe
alter
geometri
viral
addit
disrupt
viral
replic
isgyl
viral
protein
dampen
host
innat
immun
respons
isgyl
disrupt
abil
interact
compon
interferon
respons
pkr
snrna
dsrna
limit
abil
disrupt
innat
immun
isgyl
also
inhibit
human
cytomegaloviru
hcmv
gene
express
virion
releas
hcmv
known
inhibit
tumour
necrosi
induc
nuclear
shown
hcmv
protein
form
coval
noncoval
interact
isgyl
alter
stabil
inhibit
abil
suppress
therefor
isgyl
viral
protein
also
interfer
viral
modul
host
immun
respons
altogeth
exampl
illustr
abil
isgyl
viral
protein
reduc
effici
qualiti
viral
progeni
product
limit
abil
viral
protein
regul
host
immun
respons
sever
studi
found
impact
viru
egress
exampl
isgyl
viral
protein
rather
modif
host
protein
requir
viral
releas
impact
fig
first
evid
inhibit
viru
releas
came
studi
replic
cotransfect
plasmid
express
provir
dna
inhibit
releas
impact
protein
express
inhibit
monoubiquityl
gag
polyprotein
disrupt
interact
gag
host
tumour
suscept
gene
protein
requir
bud
releas
recent
studi
also
found
transport
iav
haemagglutinin
ha
cell
surfac
semiintact
cell
system
inhibit
isgyl
studi
ha
transport
restor
sampl
treat
deisgylas
ovarian
tumour
domain
otu
contain
l
protein
haemorrhag
fever
viru
cchfv
recent
studi
indic
conjug
decreas
number
multivesicular
bodi
mvb
impair
exosom
secret
trigger
aggreg
degrad
mvb
protein
lysosom
includ
also
shown
inhibit
bud
releas
ebola
viruslik
particl
vlp
avian
sarcoma
leukosi
viru
aslv
releas
ebola
vlp
requir
ubiquityl
viral
matrix
protein
mediat
host
ubiquitin
protein
ligas
coexpress
inhibit
ebola
vlp
releas
inhibit
activ
block
ubiquityl
interact
ubiquitin
conjug
enzym
prevent
ubiquitin
transfer
interestingli
recent
studi
found
itch
anoth
ubiquitin
ligas
also
interact
regul
viral
bud
via
ident
protein
domain
use
whether
antibud
function
extend
itch
ligas
well
remain
also
inhibit
aslv
vlp
releas
inhibit
recruit
host
atpas
vacuolar
protein
sortingassoci
protein
endosom
sort
complex
requir
transport
escrt
requir
aslv
inhibit
correl
isgyl
host
protein
charg
multivesicular
bodi
protein
requir
recruit
therefor
abl
limit
replic
virus
coval
noncoval
modif
host
protein
involv
protein
sort
transport
pathway
recent
studi
implic
regul
viral
latenc
kaposi
sarcomaassoci
herpesviru
kshv
caus
agent
kaposi
sarcoma
common
hivaidsassoci
cancer
worldwid
transcript
analysi
kshvinfect
primari
human
oral
fibroblast
identifi
seri
strongli
induc
isg
includ
knockdown
express
small
interf
rna
sirna
latent
infect
cell
increas
express
viral
lytic
gene
increas
virion
releas
implic
mainten
kshv
one
propos
mechan
regul
specif
kshv
microrna
known
modul
kshv
second
studi
kshv
infect
reactiv
primari
effus
lymphoma
cell
variou
mean
conjug
level
found
increas
along
activ
type
interferon
knockdown
either
ligas
result
increas
kshv
reactiv
increas
product
infecti
result
suggest
conjug
modul
kshv
replic
reactiv
viral
latenc
earli
report
note
could
releas
cell
recombin
could
stimul
product
recent
confirm
studi
individu
defici
present
increas
suscept
mycobacteri
box
studi
product
nk
cell
lymphocyt
induc
increas
cell
costimul
earlier
studi
also
implic
cytokin
activ
drive
nk
cell
prolifer
dendrit
cell
matur
neutrophil
recruit
recent
identifi
cell
surfac
receptor
bind
receptor
mediat
releas
cell
pretreat
whether
also
contribut
activ
attribut
whether
cytokinelik
activ
role
viral
infect
remain
elucid
unconjug
form
also
shown
counteract
inflammatori
respons
viral
infect
chikungunya
infect
neonat
mice
lack
found
suscept
viral
infect
howev
protect
independ
isgyl
increas
lethal
observ
mice
due
increas
viral
instead
infect
mice
develop
exagger
immun
respons
display
signific
increas
proinflammatori
cytokin
chemokin
compar
wildtyp
preliminari
data
indic
death
anim
occur
manner
consist
cytokin
storm
surviv
mice
could
prolong
treat
antibodi
separ
studi
mice
suscept
vaccinia
viru
infect
produc
elev
level
proinflammatori
cytokin
taken
togeth
find
suggest
unconjug
neg
regul
product
proinflammatori
cytokin
chemokin
certain
viral
infect
still
unclear
whether
effect
mediat
intracellular
extracellular
unconjug
cell
type
respons
increas
cytokin
product
host
respons
pathogen
includ
upregul
gene
limit
pathogen
replic
diseas
resist
protect
host
tissu
damag
independ
control
pathogen
burden
diseas
toler
recent
find
support
role
regul
diseas
toler
mous
model
iav
sendai
viru
infect
sev
protect
mice
virusinduc
vitro
vivo
analys
reveal
protect
neither
restrict
viral
replic
modul
cytokin
chemokin
product
within
lung
tissu
instead
determin
regul
damag
andor
repair
respiratori
epithelium
follow
date
evid
pathway
regul
diseas
toler
viral
infect
howev
recent
studi
identifi
pathway
target
involv
homeostasi
includ
regul
apoptosi
import
determin
facilit
diseas
toler
coordin
pathway
proteom
studi
identifi
hundr
host
protein
isgyl
upon
interferon
mani
isg
involv
regul
innat
immun
respons
includ
signal
transduc
activ
transcript
rigi
interferoninduc
protein
tetratricopeptid
repeat
pkr
interferonregul
resist
gtpbind
protein
mxa
also
known
subset
potenti
target
modif
valid
impact
isgyl
function
investig
detail
tabl
pkr
interferoninduc
protein
bind
dsrna
activ
phosphoryl
eukaryot
translat
initi
factor
inhibit
cellular
mrna
translat
pkr
isgyl
lysin
interferon
lp
isgyl
pkr
exhibit
rnaindepend
constitut
activ
result
decreas
protein
howev
remain
unclear
whether
isgyl
pkr
result
direct
antagon
viru
replic
isgyl
interferon
regulatori
factor
interfer
ubiquityl
subsequ
degrad
transcript
factor
phosphoryl
move
cytoplasm
nucleu
form
complex
crebbind
protein
crebbp
activ
transcript
addit
isg
member
stat
protein
famili
function
transcript
factor
involv
upregul
gene
induc
type
ii
iii
interferon
sev
infect
isgyl
inhibit
interact
peptidylprolyl
isomeras
nimainteract
prevent
ubiquityl
subsequ
degrad
similarli
isgyl
human
found
maintain
level
phosphoryl
activ
downstream
signal
case
result
isgyl
robust
interferon
respons
limit
viral
replic
recent
studi
individu
inherit
defici
display
sign
type
interferon
box
reveal
intracellular
unconjug
immunomodulatori
function
vitro
character
cell
isol
patient
show
elev
type
interferon
secret
hyperrespons
type
interferon
stimul
includ
prolong
phosphoryl
attribut
low
level
protein
express
defect
could
restor
either
wildtyp
nonconjugat
implic
noncoval
interact
mechanist
studi
demonstr
bind
stabil
prevent
ubiquityl
sphase
kinaseassoci
protein
fig
result
suggest
human
intracellular
unconjug
crucial
downregul
type
interferon
signal
viral
infect
consist
human
cell
prime
interferon
display
prolong
isg
express
case
provid
resist
viral
interestingli
enhanc
type
interferon
signal
observ
mice
box
rais
interest
question
diverg
function
speci
regul
interferon
signal
also
contribut
unexpect
provir
activ
associ
chronic
viral
hepat
express
member
conjug
cascad
found
upregul
individu
persist
infect
hepat
c
viru
hcv
fail
treatment
consist
vitro
studi
also
show
knockdown
increas
sensit
hcvinfect
cell
mechanist
studi
found
express
induc
condit
unphosphoryl
interferonstimul
gene
factor
fig
tripartit
transcript
factor
compos
interferon
regulatori
factor
unphosphoryl
level
significantli
increas
respons
chronic
hcv
infect
sustain
express
subset
isg
restrict
hcv
replic
sustain
express
led
stabil
level
decreas
signal
type
interferon
therefor
regul
interferon
signal
mediat
contribut
mainten
chronic
hcv
also
modul
metabol
activ
function
macrophag
host
antivir
cell
lack
defici
mitochondri
respir
oxid
phosphoryl
mitophagi
reactiv
oxygen
speci
absenc
interferonprim
bone
marrowderiv
macrophag
fail
produc
nitric
oxid
arginas
molecul
limit
vaccinia
viru
infect
although
detail
molecular
mechan
remain
unclear
find
demonstr
cell
type
also
modul
cellular
metabol
activ
pathway
also
implic
nonvir
infecti
diseas
box
noninfecti
diseas
cancer
cellular
function
regul
interferoninduc
identif
host
protein
modifi
interact
may
provid
import
insight
function
pathway
protein
ibv
first
viral
protein
identifi
immuneevas
activ
initi
found
bind
human
primat
inhibit
interact
enzym
therebi
inhibit
howev
recent
studi
recombin
ibv
engin
encod
protein
defect
bind
reveal
inhibit
isgyl
ibvinfect
cell
instead
bind
sequest
isgyl
viral
protein
particularli
isgyl
viral
prevent
incorpor
isgyl
np
vrnp
previous
shown
inhibit
viral
rna
synthesi
vaccinia
viru
protein
inhibit
conjug
promot
viral
replic
vitro
assay
vaccinia
viru
protein
bind
human
mous
antagon
infect
mous
embryon
fibroblast
mutant
vaccinia
viru
result
conjug
format
reduc
viral
replic
wildtyp
cell
compar
cell
mice
exhibit
increas
lethal
compar
wildtyp
mice
infect
mutant
vaccinia
viru
mutant
viru
also
exhibit
increas
viru
replic
cell
compar
wildtyp
result
suggest
conjug
restrict
vaccinia
viru
replic
protein
function
immuneevas
effector
sever
virus
especi
member
order
nidoviral
includ
coronavirus
encod
enzym
capabl
deconjug
ubiquitin
target
protein
antagon
host
respons
cchfv
porcin
reproduct
respiratori
syndrom
viru
pprsv
equin
arter
viru
eav
encod
l
protein
contain
otucontain
proteas
protein
shown
reduc
total
pool
ubiquitin
conjug
coronavirus
includ
sever
acut
respiratori
syndromecoronaviru
sarscov
middl
east
respiratori
syndromecoronaviru
merscov
mous
hepat
viru
strain
human
encod
papainlik
proteas
plp
also
deubiquityl
deisgyl
target
pharmacolog
inhibit
enzym
vitro
led
increas
protein
isgyl
decreas
viral
replic
recombin
sindbi
viru
system
use
cchfv
sarscov
evalu
impact
deisgyl
activ
proteas
viral
exampl
coexpress
either
cchfv
l
protein
otu
domain
sarscov
plpro
recombin
sindbi
viru
abolish
protect
provid
express
alon
infect
mice
mutat
catalyt
cystein
residu
plpro
addit
plpro
inhibitor
block
deisgyl
infect
cell
administr
plpro
inhibitor
protect
mice
lethal
infect
demonstr
efficaci
coronaviru
proteas
inhibitor
mous
model
although
exampl
highlight
anoth
potenti
mechan
circumv
direct
evid
antagon
protein
viral
infect
remain
demonstr
recent
biochem
structur
studi
reveal
viral
deconjug
enzym
differ
specif
variou
form
polyubiquitin
chain
bind
speciesspecif
therefor
biolog
consequ
differ
viral
proteas
vari
depend
upon
viru
host
conjug
inhibit
hcmv
growth
reduc
viral
gene
express
inhibit
virion
overcom
hcmv
evolv
multipl
countermeasur
major
immediateearli
protein
reduc
isg
transcript
sequest
prevent
interferonsensit
respons
element
isr
bind
ectop
express
hcmv
limit
protein
conjug
presum
decreas
express
compon
conjug
machineri
delet
viru
robustli
induc
interferon
signal
includ
express
addit
two
tegument
protein
encod
gene
involv
virion
stabil
downregul
signal
noncoval
interact
express
reduc
level
conjug
cell
cotransfect
conjug
enzym
interestingli
discuss
earlier
target
conjug
isgyl
alter
stabil
inhibit
abil
suppress
signal
absenc
hcmv
growth
sensit
treatment
conjug
limit
kshv
replic
modul
viral
kshv
protein
express
upon
tolllik
receptor
activ
interferon
induct
interact
ligas
interact
decreas
level
conjug
cellular
suggest
affect
conjug
interferon
respons
could
contribut
effect
kshv
taken
togeth
exampl
highlight
converg
evolut
viral
protein
antagon
pathway
provid
support
import
pathway
viral
pathogenesi
shown
import
role
infect
broad
rang
virus
recent
studi
advanc
understand
elucid
antagon
viral
replic
acut
latent
infect
identifi
immuneevas
strategi
begin
character
alter
diseas
pathogenesi
includ
abil
limit
tissu
damag
modul
human
type
interferon
signal
identifi
first
cell
surfac
receptor
unconjug
regul
cytokin
releas
recent
identif
subsequ
character
regul
type
interferon
signal
shed
light
complex
pathway
prompt
reevalu
role
still
mani
import
question
need
answer
pathway
fulli
understood
protein
isgyl
reshap
global
posttransl
modif
profil
infect
immun
cell
respons
pathogen
invas
isgyl
modul
viral
protein
viral
replic
host
homeostasi
still
poorli
understood
conjug
system
intim
tie
protein
translat
also
result
target
modif
protein
outlin
modif
small
fraction
total
pool
protein
affect
overal
function
within
cell
still
unclear
possibl
includ
abil
isgyl
protein
disrupt
oligomer
protein
alter
cellular
local
protein
anoth
intrigu
possibl
isgyl
could
serv
warn
sign
cell
infect
recent
studi
shown
interact
autophagi
pathway
known
regul
varieti
process
includ
protein
degrad
antigen
present
cytokin
signal
cell
isgyl
protein
interact
autophagi
pathway
cellular
pathway
yet
determin
could
function
danger
signal
activ
host
respons
could
serv
limit
infect
protect
host
applic
novel
proteom
crucial
determin
conjug
prefer
scope
potenti
biolog
outcom
protein
isgyl
although
initi
proteom
studi
identifi
isgyl
protein
perform
interferonstimul
cell
analysi
need
expand
differ
cell
type
virus
role
extracellular
host
respons
virus
util
tool
inhibit
conjug
allow
research
begin
deciph
whether
phenotyp
attribut
defici
conjugationdepend
independ
howev
tool
differenti
function
unconjug
extracellular
intracellular
lack
recent
identif
receptor
may
facilit
biolog
character
extracellular
intracellular
unconjug
modul
cellular
pathway
limit
pathogen
burden
damag
infect
vivo
studi
provid
evid
function
viral
pathogenesi
limit
tissu
damag
independ
abil
directli
antagon
viral
abil
noncoval
bind
regul
type
interferon
signal
human
indic
may
interact
unidentifi
intracellular
protein
independ
conjug
regul
addit
cellular
process
uncov
bind
partner
instrument
understand
molecular
mechan
action
recent
year
use
marker
antivir
immun
adjuv
enhanc
cell
antitumour
character
isgyl
pathway
could
help
identifi
druggabl
target
offer
new
opportun
interven
progress
mani
diseas
